Infusion pump companies are perpetuating misconceptions.
The center will start phasing in efficiencies on March 18.
Adhesives are ubiquitous. With virtually limitless applications, the retail stick-to skin market is a good choice for companies looking to expand their product offerings.
The strategic acquisitions expand the company’s structural heart disease technologies.
Reparative medicine technology is an option to delay or avoid orthopedic surgery.
The resignation will be effective in about a month, according to reports.
The regulation is bringing digital enablement to the forefront, requiring electronic instructions for use.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
Technologically superior devices, favorable research outcomes and a supportive regulatory structure are fueling growth.
The new pump allows patients to customize their diabetes management.